Amodia Bioservice

AMODIA Bioservice is a privately held German diagnostics and services company leveraging nucleic-acid-based technologies to identify and quantify microorganisms. Its core business model revolves around providing customized testing services and kits, notably for industrial bioprocess optimization like biogas production, as well as developing rapid test strips such as its MultiFlow® line. The company is revenue-generating, operating in a specialized niche of applied molecular diagnostics outside of human therapeutics, with growth tied to industrial microbiology and research partnerships.

Nucleic-acid-based (molecular) detection methods for microorganisms, including proprietary multiplex lateral flow test strips (MultiFlow® platform).

AMODIA competes with large life science tools companies (e.g., Qiagen, Thermo Fisher) offering molecular detection services, as well as specialized environmental testing labs and academic core facilities. Its differentiation lies in customized service, application-specific expertise (e.g., biogas), and user-friendly product formats like the MultiFlow® strips.